HTA - Health Technology Assessment Report Ivacaftor (Kalydeco) for an additional 8 mutations in cystic fibrosis (licence extension) Year: 2014 Date: 2014 Author: NIHR HSC Source Health Technology Assessment Database - NIHR Horizon Scanning Centre (NIHR HSC) Study design (if review, criteria of inclusion for studies) HTA report Interventions Ivacaftor (Kalydeco) Related topics CFTR modulators therapy